Checkpoint inhibitors are a revolutionary type of drug that use the immune system to destroy cancer cells. First approved in 2011, these drugs are constantly evolving, with new combinations and targets appearing regularly. While some have expanded their usage, others have faced challenges related to safety concerns and efficacy. This rapidly evolving field promises new developments in the fight against cancer, with various clinical trials and studies currently underway.
Navigating Cybersecurity Frameworks – CISO Resource Guide
The role of the Chief Information Security Officer (CISO) is crucial amid evolving cyber threats. Selecting the right cybersecurity framework aligns risk management with organizational
%20CISO%E2%80%99s%20Core%20Focus.webp?w=0&resize=0,0&ssl=1 "Identity and Access Management (IAM)")
